BioLife Solutions, Inc. (BLFS)

BioLife Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,168	1,204	732	778	1,552	1,306
Market Cap Growth	27.49%	64.50%	-5.95%	-49.85%	18.87%	294.61%
Enterprise Value	1,047	1,209	735	761	1,505	1,213
Last Close Price	23.71	25.96	16.25	18.20	37.27	39.89
PE Ratio	-	-	-	-	-	716.70
PS Ratio	12.56	14.64	9.65	10.21	13.03	27.16
PB Ratio	3.20	3.45	2.17	2.14	3.25	6.36
P/TBV Ratio	8.58	9.48	6.46	7.25	15.34	11.28
P/FCF Ratio	115.86	384.00	-	-	-	-
P/OCF Ratio	77.06	142.83	-	-	-	196.51
EV/Sales Ratio	11.93	14.70	9.69	9.98	12.63	25.22
EV/EBITDA Ratio	-	-	-	-	-	818.78
EV/FCF Ratio	107.57	385.62	-	-	-	-
Debt / Equity Ratio	0.08	0.09	0.10	0.12	0.06	0.05
Debt / EBITDA Ratio	8.93	19.84	-	-	-	3.78
Debt / FCF Ratio	2.77	9.62	-	-	-	-
Asset Turnover	0.22	0.20	0.18	0.15	0.30	0.29
Inventory Turnover	0.86	1.02	0.96	0.93	4.05	1.79
Quick Ratio	3.53	3.48	1.24	2.17	2.18	6.32
Current Ratio	4.73	4.55	2.86	3.11	2.95	7.37
Return on Equity (ROE)	-2.52%	-3.32%	-5.26%	0.09%	-2.61%	1.59%
Return on Assets (ROA)	-0.79%	-1.10%	-3.71%	-1.33%	-4.68%	-1.37%
Return on Capital (ROIC)	-0.84%	-1.19%	-4.11%	-1.46%	-5.12%	-1.72%
Earnings Yield	-0.92%	-1.68%	-9.29%	-17.96%	-0.57%	0.15%
FCF Yield	0.86%	0.26%	-3.24%	-2.88%	-1.25%	-0.09%
Buyback Yield / Dilution	-4.90%	-5.37%	-1.50%	-11.87%	-41.01%	-40.32%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q